QuidelOrtho Corporation QDEL Number of executive defendants

Other financials

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total equity$1.9B-38.2%

Total assets$5.6B-12.9%

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Market cap$921.94M-51.4%

Enterprise value$3.88B-20.1%

P/S0.4×-0.3×

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:LossContingencyNumberOfExecutiveDefendants.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is QuidelOrtho Corporation's number of executive defendants?: QuidelOrtho Corporation (QDEL) reported number of executive defendants of 3 in Q1 2025.